Ampio Pharmaceuticals (FRA:APH0) OCF Margin %: 0.00% (As of Dec. 2023)


FRA:APH0 Ampio Pharmaceuticals Inc FRA:APH0
35 GF Score
Price €3.62
View Full Analysis

What is Ampio Pharmaceuticals OCF Margin %?

Ampio Pharmaceuticals FRA:APH0 35 OCF Margin % is 0.00% as of Dec. 2023. GuruFocus rates FRA:APH0 with a GF Score™ of 35/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Ampio Pharmaceuticals's Cash Flow from Operations for the three months ended in Dec. 2023 was €-2.12 Mil. Ampio Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was €0.00 Mil. Therefore, Ampio Pharmaceuticals's OCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Ampio Pharmaceuticals's current OCF Yield % is -264,100.00%.

The historical rank and industry rank for Ampio Pharmaceuticals's OCF Margin % or its related term are showing as below:


FRA:APH0's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Ampio Pharmaceuticals OCF Margin % Related Terms

Ampio Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Ampio Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ampio Pharmaceuticals OCF Margin % Chart

Ampio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ampio Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:APH0
35GF Score
Ampio Pharmaceuticals Inc FRA:APH0
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ampio Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Ampio Pharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-7.853/0
= %

Ampio Pharmaceuticals's OCF Margin for the quarter that ended in Dec. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-2.117/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Ampio Pharmaceuticals (FRA:APH0) has a OCF Margin % of 0.00% as of Dec. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ampio Pharmaceuticals and its competitors.
Is Ampio Pharmaceuticals' OCF Margin % too high?
Ampio Pharmaceuticals' current OCF Margin % is 0.00%. Overall, Ampio Pharmaceuticals has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Ampio Pharmaceuticals' OCF Margin % compare to EFTR and VBIVQ?
Ampio Pharmaceuticals' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ampio Pharmaceuticals and its competitors. Ampio Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ampio Pharmaceuticals stock overvalued right now?
Ampio Pharmaceuticals (FRA:APH0) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Ampio Pharmaceuticals' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Ampio Pharmaceuticals (FRA:APH0), the current OCF Margin % is 0.00% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ampio Pharmaceuticals Business Description

Address 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201).
35GF Score

Get the complete analysis for FRA:APH0

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.62
Price